Patent · US Expired

Monoclonal antibody directed to human ganglioside GD.sub.2

US4675287A · kind A · utility

42Cited by

2References

20Claims

0Family size

Assignee

Scripps Clinic and Research Foundation · US

Inventors

Ralph A. Reisfeld · Village of La Jolla, US
Gregor Schulz · Umkirch, DE

Key dates

Filing date	Jul 26, 1984
Grant date	Jun 23, 1987
Priority date	—
Expiry date	Jul 26, 2004

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/866
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A non-human, mammalian monoclonal receptor produced and secreted by a hybridoma having the ATCC accession number HB 8568 and methods of preparing and using same, as well as diagnostics utilizing the receptor are disclosed. The monoclonal receptor reacts with cells such as human neuroectodermal tumors having ganglioside GD.sub.2 antigen expressed on their cellular membrane surfaces.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.